Results 201 to 210 of about 38,316 (246)

Engineering TME-activated CD47-specific CAR macrophage via Arg1 promoter for safe and effective solid tumor immunotherapy. [PDF]

open access: yesJ Immunother Cancer
Du F   +13 more
europepmc   +1 more source

CD47 monoclonal antibodies differ in their capacity to induce immune response. [PDF]

open access: yesEur J Microbiol Immunol (Bp)
Cham LB   +6 more
europepmc   +1 more source

Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits [PDF]

open access: yes, 2017
Barata, Llilda   +9 more
core   +1 more source

Targeting tumor-infiltrating regulatory T cells: combining CD47 and PD-L1 inhibition via a novel aptamer-siRNA chimera. [PDF]

open access: yesMol Biomed
Zeng Y   +11 more
europepmc   +1 more source

Acute CD47 blockade during ischemic myocardial reperfusion enhances phagocytosis-associated cardiac repair [PDF]

open access: yes, 2017
Burridge, Paul W   +13 more
core   +2 more sources

Expression of CD47, Aldehyde Dehydrogenase, and SOX4 Stem Cells in Different Colonic Lesions

open access: diamond
Mohammed Abd El Salam Abd El Fattah Badran   +5 more
openalex   +1 more source

miR-96-5p-mediated Inhibition of CD47 contributes to pancreatic tumor regression via activating both innate and adaptive anti-tumor immunity. [PDF]

open access: yesCell Commun Signal
Tong S   +12 more
europepmc   +1 more source

CD47 blockade triggers T cell–mediated destruction of immunogenic tumors

open access: green, 2015
Xiaojuan Liu   +9 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy